Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Arcadia Biosciences (RKDA) Asset Utilization Ratio (2016 - 2025)

Arcadia Biosciences' Asset Utilization Ratio history spans 11 years, with the latest figure at 0.64 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio rose 82.99% year-over-year to 0.64; the TTM value through Dec 2025 reached 0.64, up 82.99%, while the annual FY2025 figure was 0.48, 59.45% up from the prior year.
  • Asset Utilization Ratio reached 0.64 in Q4 2025 per RKDA's latest filing, up from 0.63 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 20.48 in Q1 2022 to a low of 0.08 in Q3 2023.
  • Average Asset Utilization Ratio over 5 years is 3.31, with a median of 0.36 recorded in 2022.
  • Peak YoY movement for Asset Utilization Ratio: soared 35218.52% in 2021, then plummeted 121.19% in 2023.
  • A 5-year view of Asset Utilization Ratio shows it stood at 16.37 in 2021, then crashed by 99.45% to 0.09 in 2022, then soared by 138.4% to 0.21 in 2023, then surged by 64.53% to 0.35 in 2024, then surged by 82.99% to 0.64 in 2025.
  • Per Business Quant, the three most recent readings for RKDA's Asset Utilization Ratio are 0.64 (Q4 2025), 0.63 (Q3 2025), and 0.52 (Q2 2025).